Skip to content
  • Sunday, 16 August 2026
  • 6:30 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations
Laboratory Automation & Robotics

FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations

Lana Keisha Jul 19, 2026 0

FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently navigating a period of unprecedented expansion, marked by…

Read More
Laboratory Automation & Robotics

FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations

Lana Keisha Jul 11, 2026 0

FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently executing a monumental expansion strategy, with approximately $7…

Read More
Laboratory Automation & Robotics

FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations

Lana Keisha Jul 4, 2026 0

FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently navigating an unprecedented phase of strategic expansion, marked…

Read More
Laboratory Automation & Robotics

FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations

Lana Keisha Jun 27, 2026 0

FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently experiencing an unprecedented period of expansion, marked by…

Read More
Bristol Myers Squibb and Hengrui Pharma Forge Landmark $15.2 Billion Oncology and Immunology CollaborationFrom Staple Food to Smart Material Scientists Uncover Rices Surprising Mechanical Properties for Next-Generation EngineeringStanford Medicine Discovery Reveals Glucose as a Master Regulator of Stem Cell Differentiation and Tissue DevelopmentUS Imposes 100% Tariff on Branded Pharmaceuticals, Sparking Industry Concerns and Geopolitical Debate
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ